Medical Device Global Market Access cover art

Medical Device Global Market Access

Medical Device Global Market Access

By: Pure Global
Listen for free

About this listen

Navigate every market. Accelerate every launch. Medical Device Global Market Access by Pure Global is the audio briefing that turns the world’s most confusing regulatory pathways into clear, actionable roadmaps. If you’re a MedTech founder, RA/QA leader, product manager, or investor who needs to get devices cleared anywhere from Austin to Abu Dhabi, this show is your shortcut. Why listen? • Step-by-step playbooks – We decode EU MDR, U.S. 510(k), Brazil’s ANVISA, China’s NMPA, and 25 + other regimes, showing exactly how long each milestone really takes and where companies get stuck. • First-hand war stories – Hear candid interviews with regulatory veterans who have shepherded implants, software, wearables, diagnostics, and AI algorithms to market—and lived to tell the tale. • Real-time intelligence – Every episode covering the week’s new guidances, standards, and enforcement trends so you’re always ahead of the curve. • Actionable templates – From clinical evaluation checklists to technical-file skeletons, we break down the documents you’ll need and the pitfalls reviewers love to flag. • AI-powered insights – Because Pure Global mines millions of public filings, tenders, and recalls, we surface data-backed best practices you won’t hear at conferences—or from competitors. What you’ll hear • Launching SaMD under multiple risk classes in parallel • Surviving an unannounced ISO 13485 audit • Building a “reg-first” QMS that scales • Mastering Latin-American registrations without endless language cycles • Leveraging real-world evidence to shorten clinical timelines • Aligning cybersecurity, privacy, and post-market surveillance rules across regions Whether you’re plotting first entry, managing lifecycle expansions, or rescuing a delayed submission, subscribing could shave months—and millions—off your path to revenue. ⸻ Brought to you by Pure Global – the AI-native consultancy that already guides MedTech innovators through regulatory and market-access hurdles in 30 + countries. Ready for expert help on your next submission? Visit https://pureglobal.com or email info@pureglobal.com to start accelerating today.Copyright 2026 Pure Global
Episodes
  • EU Medical Device Cybersecurity: Navigating MDCG 2019-16 Under MDR & IVDR
    Feb 6 2026
    This episode delves into the critical requirements for medical device cybersecurity in the European Union. We explore the concept of "state of the art" as defined by the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), focusing on the key guidance document, MDCG 2019-16 Rev. 1. Learn how this guidance impacts your design controls, risk management, post-market surveillance, and change management processes to avoid common and costly audit nonconformities. - What does "state of the art" mean for medical device cybersecurity in the EU? - Why is MDCG 2019-16 Rev. 1 a critical document for your technical file? - How do you integrate "secure by design" principles into your product lifecycle? - Are your post-market surveillance activities adequately addressing cybersecurity vulnerabilities? - When does a cybersecurity patch trigger a significant change notification to your Notified Body? - What are the most common cybersecurity-related nonconformities in MDR and IVDR audits? - How does vulnerability handling connect to your vigilance reporting obligations? Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies. We develop efficient regulatory strategies and use advanced AI to compile and submit technical dossiers, ensuring compliance with complex requirements like cybersecurity. Our experts provide continuous regulatory monitoring to keep you ahead of changes that impact your market access. With a presence in over 30 markets, we act as your local representative, managing post-market surveillance and ensuring ongoing compliance. Let us help you navigate the global landscape. Contact us at info@pureglobal.com, visit https://pureglobal.com, or explore our FREE AI tools and database at https://pureglobal.ai.
    Show More Show Less
    3 mins
  • EU AI Act & MDR/IVDR: Decoding the New Dual Compliance Roadmap for AI Medical Devices
    Feb 5 2026
    This episode explores the critical intersection of the new European Union AI Act and the existing Medical Device and In-Vitro Diagnostic Regulations (MDR/IVDR). We unpack the challenges of dual compliance for manufacturers of AI-enabled medical devices and explain how the recent joint guidance from the Medical Device Coordination Group and the Artificial Intelligence Board (MDCG 2025-6 / AIB 2025-1) provides a much-needed roadmap for integrating these two complex regulatory frameworks. Key Questions: - What is the EU AI Act and how does it specifically impact medical device manufacturers? - How do the requirements of the AI Act overlap with the existing MDR and IVDR? - What new information must be included in your technical documentation for an AI-enabled device? - How should risk management under ISO 14971 be integrated with the AI Act's risk framework? - What are the new post-market monitoring obligations specifically for AI systems? - Will your current Notified Body be able to assess your device for AI Act compliance? - What are the key deadlines that manufacturers need to be planning for right now? Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies, combining local expertise with advanced AI to streamline global market access. We develop efficient regulatory strategies, act as your local representative in over 30 markets, and use powerful data tools to compile technical dossiers and monitor regulatory changes. To access global markets faster, visit us at https://pureglobal.com or contact info@pureglobal.com. Be sure to explore our FREE AI tools and extensive regulatory database at https://pureglobal.ai to support your compliance activities.
    Show More Show Less
    3 mins
  • EU SaMD Regulations: Mastering App Store Compliance and 'Making Available' Rules
    Feb 4 2026
    This episode explores the critical new regulatory focus from Europe's Medical Device Coordination Group (MDCG) on Software as a Medical Device (SaMD) distributed via online platforms. We discuss how the concept of 'making available on the market' now directly applies to app stores, forcing manufacturers to integrate platform listings, version control, and geographic restrictions into their core compliance and Quality Management Systems to avoid significant penalties. Key Questions: - What does 'making available on the market' mean for a medical app? - How can your app store listing create a serious compliance risk? - Are you responsible for ensuring only the correct version of your SaMD is downloadable? - How do you manage updates and change notices for an app distributed to thousands of users? - Can you use an app store's geographic restrictions to manage regulatory approvals? - What are the consequences of non-compliance for SaMD on digital marketplaces? - How does this new guidance impact your Quality Management System (QMS)? Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies, streamlining global market access with a powerful combination of local expertise and advanced AI. For SaMD innovators, our experts develop efficient regulatory strategies and help manage technical dossiers for submission to authorities worldwide. We ensure your product remains compliant through post-market surveillance and continuous regulatory monitoring. Our AI-powered data tools can accelerate your research and document management. Let us help you navigate the complexities of global expansion. Visit us at https://pureglobal.com, contact info@pureglobal.com, or explore our free AI tools and database at https://pureglobal.ai.
    Show More Show Less
    3 mins
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.